Chuck Olson, PhD
Chief Technology Officer
Dr. Olson is a biotechnology industry professional with broad scientific and operational experience, having a focus in process development, manufacturing and other CMC related activities for many clinical and commercial products. With over forty years of experience, he is a true veteran, having enabled the production of virtually every class and size of biological product from recombinant proteins, enzymes, blood products, natural products, adenovirus and whole cell immunotherapies. His diverse background includes the positions of COO at Dendreon (Provenge), Sr VP of Operations at Applied Molecular Transport, CTO for Anthera Pharmaceuticals, VP and Site Head of Operations for Cell Genesys, Senior Director of Manufacturing, Facilities and Process Development for BioMarin Pharmaceuticals (Aldurazyme and Naglazyme), Staff Scientist and Scientist at Bayer (Kogenate) and Genentech (Activase and Xolair), respectively. He has a bachelor’s degree in biology and chemistry, a master’s in chemistry and a DSc in biochemistry.